Last reviewed · How we verify

L-arginine (L-arginine Veyron) — Competitive Intelligence Brief

L-arginine (L-arginine Veyron) (L-arginine (L-arginine Veyron)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Amino acid supplement. Area: Cardiovascular.

marketed Amino acid supplement Nitric oxide synthase (substrate) Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

L-arginine (L-arginine Veyron) (L-arginine (L-arginine Veyron)) — University Hospital, Strasbourg, France. L-arginine is a semi-essential amino acid that serves as a substrate for nitric oxide synthase, increasing nitric oxide production to improve vascular function and blood flow.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
L-arginine (L-arginine Veyron) TARGET L-arginine (L-arginine Veyron) University Hospital, Strasbourg, France marketed Amino acid supplement Nitric oxide synthase (substrate)
L-Arginine L-Arginine The University of Texas at Arlington marketed Amino acid supplement Nitric oxide synthase substrate
L-Serine L-Serine Elijah W. Stommel marketed Amino acid supplement
L-Tryptophan L-Tryptophan McMaster University marketed Amino acid supplement
L-Histidine L-Histidine University of Miami marketed Amino acid supplement
5-Hydroxytryptophan 5-Hydroxytryptophan Elizabeth Berry-Kravis marketed Serotonin precursor / amino acid supplement Aromatic amino acid decarboxylase (enzyme substrate); indirect serotonin system modulation
L-lysine L-lysine University of Zurich marketed Amino acid supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Amino acid supplement class)

  1. Air Force Military Medical University, China · 1 drug in this class
  2. Elijah W. Stommel · 1 drug in this class
  3. Hadassah Medical Organization · 1 drug in this class
  4. Keith D Lindor, M.D. · 1 drug in this class
  5. McMaster University · 1 drug in this class
  6. The University of Texas at Arlington · 1 drug in this class
  7. Ukrainian Medical Stomatological Academy · 1 drug in this class
  8. University Hospital, Strasbourg, France · 1 drug in this class
  9. University of Colorado, Denver · 1 drug in this class
  10. University of Miami · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). L-arginine (L-arginine Veyron) — Competitive Intelligence Brief. https://druglandscape.com/ci/l-arginine-l-arginine-veyron. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: